Variable | No. of trials/comparisons | SMD | 95% CI | I2 | Tau2 | P for interaction |
---|---|---|---|---|---|---|
All trials, physical function | 33/43 | − 0.50 | − 0.61, − 0.40 | 64% | 0.07 | – |
Fixed-effect model | − 0.53 | − 0.57, − 0.45 | ||||
Intervention | 0.08 | 0.42 | ||||
Pharmacological | − 0.53 | − 0.64, − 0.42 | ||||
Non-pharmacological | − 0.40 | − 0.74, − 0.05 | ||||
Intervention | 0.08 | 0.44 | ||||
Biological treatment | − 0.57 | − 0.68, − 0.46 | ||||
Other treatment | − 0.46 | − 0.63, − 0.28 | ||||
All trials, pain | 30/41 | − 0.48 | − 0.66, − 0.30 | 87% | 0.28 | – |
Fixed-effect model | − 0.50 | − 0.56, − 0.44 | ||||
Intervention | 0.19 | < 0.001 | ||||
Pharmacological | − 0.64 | − 0.78, − 0.49 | ||||
Non-pharmacological | 0.26 | − 0.20, 0.72 | ||||
Intervention | 0.29 | 0.28 | ||||
Biological treatment | − 0.64 | − 0.80, − 0-49 | ||||
Other treatment | − 0.41 | − 0.68, − 0.14 | ||||
All trials, spinal mobility | 30/45 | − 0.32 | − 0.48, − 0.17 | 83% | 0.21 | – |
Fixed-effect model | − 0.32 | − 0.38, − 0.26 | ||||
Intervention | 0.19 | 0.28 | ||||
Pharmacological | − 0.35 | − 0.51, − 0.19 | ||||
Non-pharmacological | − 0.02 | − 0.61, 0.56 | ||||
Intervention | 0.33 | 0.65 | ||||
Biological treatment | − 0.31 | − 0.47, − 0.15 | ||||
Other treatment | − 0.28 | − 0.52, − 0.03 | ||||
All trials, spinal stiffness | 25/34 | − 0.59 | − 0.74, − 0.44 | 75% | 0.14 | – |
Fixed-effect model | − 0.61 | − 0.68, − 0.54 | ||||
Intervention | 0.18 | 0.95 | ||||
Pharmacological | − 0.60 | − 0.76, − 0.44 | ||||
Non-pharmacological | − 0.61 | − 0.93, − 0.29 | ||||
Intervention | 0.16 | 0.34 | ||||
Biological treatment | − 0.77 | − 0.88, − 0.65 | ||||
Other treatment | − 0.55 | − 0.75, − 0.35 | ||||
All trials, PGA | 21/28 | − 0.71 | − 0.89, − 0.54 | 83% | 0.18 | – |
Fixed-effect model | − 0.74 | − 0.81, − 0.67 | ||||
Intervention | 0.19 | 0.15 | ||||
Pharmacological | − 0.77 | − 0.96, − 0.59 | ||||
Non-pharmacological | − 0.37 | − 0.81, 0.07 | ||||
Intervention | ||||||
Biological treatment | − 0.84 | − 1.09, − 0.60 | 0.20 | 0.23 | ||
Other treatment | − 0.60 | − 0.87, − 0.34 | ||||
All trials, PJ/E | 15/15 | 0.05 | − 0.11, 0.22 | 68% | 0.06 | – |
Fixed-effect model | 0.00 | − 0.08, 0.09 | ||||
Intervention | 0.00 | < 0.001 | ||||
Pharmacological | − 0.06 | − 0.15, 0.03 | ||||
Non-pharmacological | 0.99 | 0.63, 1.35 | ||||
Intervention | 0.04 | 0.02 | ||||
Biological treatment | − 0.10 | − 0.20, − 0.01 | ||||
Other treatment | 0.27 | − 0.10, 0.64 | ||||
All trials, acute phase reactants | 27/31 | − 0.51 | − 0.70, − 0.32 | 84% | 0.22 | – |
Fixed-effect model | − 0.62 | − 0.69, − 0.55 | ||||
Intervention | – | – | ||||
Pharmacological | − 0.51 | − 0.70, − 0.32 | ||||
Non-pharmacological | – | – | ||||
Intervention | 0.12 | 0.001 | ||||
Biological treatment | − 0.77 | − 1.02, − 0.52 | ||||
Other treatment | − 0.22 | − 0.37, − 0.07 | −0.07 | |||
All trials, spine radiographs | 1/1 | 0.96 | 0.22, 1.69 | – | – | – |
Fixed-effect model | – | – | ||||
Intervention | – | – | ||||
Pharmacological | – | – | ||||
Non-pharmacological | – | – | ||||
Intervention | ||||||
Biological treatment | ||||||
Other treatment | 0.96 | 0.22, 1.69 | ||||
All trials, fatigue | 3/4 | − 0.65 | − 0.82, − 0.48 | 0% | 0.00 | – |
Fixed-effect model | − 0.65 | − 0.82, − 0.48 | ||||
Intervention | – | – | ||||
Pharmacological | − 0.65 | − 0.82, − 0.48 | ||||
Non-pharmacological | – | – | ||||
Intervention | – | – | ||||
Biological treatment | − 0.65 | − 0.82, −0.48 | ||||
Other treatment |